CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-18 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,250 | $8.04 | $10K | 3,487 |
| 2024-03-18 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,750 | $31.27 | $55K | 1,737 |
| 2024-03-18 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 16,043 | ||
| 2024-03-18 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,250 | 43,334 | ||
| 2024-02-27 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,909 | $20.24 | $39K | 3,646 |
| 2024-02-27 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,909 | $30.00 | $57K | 1,737 |
| 2024-02-27 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,909 | 48,091 | ||
| 2024-02-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +500 | $6.49 | $3K | 2,237 |
| 2024-02-16 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,250 | $8.04 | $10K | 3,487 |
| 2024-02-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,750 | $27.67 | $48K | 1,737 |
| 2024-02-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −500 | 16,543 | ||
| 2024-02-16 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,250 | 44,584 | ||
| 2024-02-08 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,332 | $6.49 | $9K | 3,069 |
| 2024-02-08 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,332 | $27.50 | $37K | 1,737 |
| 2024-02-08 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +2,916 | $8.04 | $23K | 4,653 |
| 2024-02-08 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −2,916 | $27.50 | $80K | 1,737 |
| 2024-02-08 | Bizily Scott Chief Legal Officer | Option exercise 10b5-1 | +1,996 | $15.78 | $31K | 3,733 |
| 2024-02-08 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,996 | $27.50 | $55K | 1,737 |
| 2024-02-08 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,332 | 17,043 | ||
| 2024-02-08 | Bizily Scott Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,916 | 45,834 |
Page 9 of 16 · 319 trades